(Q44095490)

29 November 2017

title

Benefits of immunotherapy with a standardized Dermatophagoides pteronyssinus extract in asthmatic children: a three-year prospective study (English)

1 reference

Dermatophagoides pteronyssinus

29 November 2017

0 references

1 reference

object named as

Dermatophagoides pteronyssinus

1 reference

Pifferi M

1

1 reference

29 November 2017

Baldini G

2

1 reference

29 November 2017

Marrazzini G

3

1 reference

29 November 2017

Baldini M

4

1 reference

29 November 2017

Ragazzo V

5

1 reference

29 November 2017

Pietrobelli A

6

1 reference

29 November 2017

Boner AL

7

1 reference

29 November 2017

publication date

1 September 2002

1 reference

29 November 2017

1 reference

29 November 2017

volume

57

1 reference

29 November 2017

issue

9

1 reference

29 November 2017

page(s)

785-790

1 reference

The future for immunotherapy

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23498.X

Childhood asthma: application of the international view of management in Australia and New Zealand

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23498.X

Controlled trial of hyposensitisation to Dermatophagoides pteronyssinus in children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23498.X

Efficacy of specific immunotherapy in allergic asthma: myth or reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23498.X

A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23498.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23498.X

Specific immunotherapy in rhinitis and asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23498.X

Mucosal inflammation in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23498.X

Asthma. From bronchoconstriction to airways inflammation and remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23498.X

A 10 year follow up of 180 adults with bronchial asthma: factors important for the decline in lung function

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23498.X

Specific immunotherapy in asthma: is it effective?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23498.X

Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23498.X

Does allergen immunotherapy alter the natural course of allergic disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23498.X

Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23498.X

Position paper: Immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23498.X

7 January 2021

A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. I. Clinical results

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23498.X

7 January 2021

Standardization of spirometry--1987 update. Statement of the American Thoracic Society

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23498.X

7 January 2021

Intrasubject between-day variability of PD20 methacholine assessed by the dosimeter inhalation test

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23498.X

7 January 2021

Specific immunotherapy with Dermatophagoides pteronyssinus and D. farinae results in decreased bronchial hyperreactivity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23498.X

7 January 2021

Effect of specific immunotherapy with house dust mite extract on the bronchial responsiveness of paediatric asthma patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23498.X

7 January 2021

Immunotherapy in cat-induced asthma. Double-blind trial with evaluation of in vivo and in vitro responses

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23498.X

7 January 2021

Immunotherapy with partially purified and standardized animal dander extracts. I. Clinical results from a double-blind study on patients with animal dander asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23498.X

7 January 2021

Significant reduction of nonspecific bronchial reactivity in patients with Dermatophagoides pteronyssinus-sensitive allergic asthma under therapy with allergen-antibody complexes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23498.X

7 January 2021

Clinical effects of hyposensitization using a purified allergen preparation from Timothy pollen as compared to crude aqueous extracts from Timothy pollen and a four-grass pollen mixture respectively

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23498.X

7 January 2021

Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. I. In vivo and in vitro parameters after a short course of treatment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23498.X

7 January 2021

Cat- or dog-induced immediate and late asthmatic responses before and after immunotherapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23498.X

7 January 2021

A controlled trial of immunotherapy for asthma in allergic children

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23498.X

7 January 2021

Do asthmatic children benefit from specific immunotherapy?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23498.X

7 January 2021

Computed tomography of the lungs in asthma: influence of disease severity and etiology

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23498.X

7 January 2021

Immunotherapy and allergic inflammation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23498.X

7 January 2021

Relations of bronchial responsiveness to allergy skin test reactivity, lung function, respiratory symptoms, and diagnoses in thirteen-year-old New Zealand children

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23498.X

7 January 2021

Immunotherapy with standardized extract of Dermatophagoides pteronyssinus in bronchial asthma: a dose-titration study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23498.X

7 January 2021

10.1034/J.1398-9995.2002.23498.X

Identifiers

DOI

1 reference

29 November 2017

1 reference